Navigation Links
ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer
Date:11/24/2008

1941, the mission of the American Society for Gastrointestinal Endoscopy is to be the leader in advancing patient care and digestive health by promoting excellence in gastrointestinal endoscopy. ASGE, with nearly 11,000 members worldwide, promotes the highest standards for endoscopic training and practice, fosters endoscopic research, recognizes distinguished contributions to endoscopy, and is the foremost resource for endoscopic education. Visit www.asge.org and www.screen4coloncancer.org for more information.

About Endoscopy

Endoscopy is performed by specially-trained physicians called endoscopists using the most current technology to diagnose and treat diseases of the gastrointestinal tract. Using flexible, thin tubes called endoscopes, endoscopists are able to access the human digestive tract without incisions via natural orifices. Endoscopes are designed with high-intensity lighting and fitted with precision devices that allow viewing and treatment of the gastrointestinal system.

CONTACT: Anne Brownsey of American Society for Gastrointestinal Endoscopy, +1-630-570-5635, abrownsey@asge.org


'/>"/>
SOURCE American Society for Gastrointestinal Endoscopy
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer
2. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
3. Mayo Clinic Study Finds Further Association Between Diabetes and Pancreatic Cancer
4. Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer
5. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
6. Senescos Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
7. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
8. Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging
9. Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy With No Dose Limiting Toxicity in Metastatic Pancreatic Cancer
10. Patients with Pancreatic Cancer Can Benefit From Avastin(R) Plus Tarceva(R)
11. Anti-TGF-Beta Antisense AP 12009 Shows Very Good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma, Malignant Melanoma and Colorectal Carcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Mass., Dec. 16 Boston Scientific Corporation (NYSE: ... Board of Directors has elected Nelda Connors as a ... of the Electrical and Metal Products division of Tyco ... Eaton Corporation, holding several positions in operations and general ... in a number of executive and management capacities with ...
(Date:12/16/2009)... Mass., Dec. 16 According to Millennium ... technology market intelligence, health care reforms in China ... market in 2009, and will continue to fuel ... Asia Pacific Markets for Interventional Cardiology Devices ... the Chinese government will allow the Chinese drug-eluting ...
(Date:12/16/2009)... /PRNewswire/ -- Sanofi Pasteur, the ... today that it has entered into an ... develop and commercialize its prophylactic vaccine against ... aureus or MRSA. MRSA are responsible ... referred to as multidrug-resistant Staphylococcus aureus ...
Breaking Medicine Technology:Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 2Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group 3Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 2Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 3Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 4Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs Zicam Cold Remedy Nasal Gel 49143 1Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs Zicam Cold Remedy Nasal Gel 49143 2Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs Zicam Cold Remedy Nasal Gel 49143 3Wisconsin Doctor Raj Ambay Elected to the AMA Board of Trustees 49142 1Wisconsin Doctor Raj Ambay Elected to the AMA Board of Trustees 49142 2LA County Calls for Repeal of Federal Cell Tower Health Preemption 49140 1LA County Calls for Repeal of Federal Cell Tower Health Preemption 49140 2
... EPOC Results Published in March 22 Issue ... March 20 Sanofi-aventis,today announced that efficacy ... Intergroup study published in the March 22 ... patients Eloxatin(R) (oxaliplatin injection) in,combination with 5-fluorouracil/leucovorin ...
... NanoBio Corporation,announced today that it has seen promising ... study of NB-002, a topical lotion for onychomycosis ... clearly,justify completing the study, according to NanoBio scientists., ... out a clear nail after,successfully treating the infection ...
Other Medicine Technology:Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases 2Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases 3Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases 4Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases 5NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis 2
(Date:12/16/2009)... of Medicine,s (BUSM) Pulmonary Center has received a ... Lung, and Blood Institute to derive stem cells ... , Darrell Kotton, MD, associate professor of ... assistant professor of medicine, are the principal investigators ... Mostoslavsky lead a multicenter investigative team of five ...
(Date:12/16/2009)... honored to announce that Chris Wepfer and Jackie Kirby have ... Healthcare Traveler magazine’s 2009 Recruiters of the Year Showcase. This ... honors and the first for Jackie. , ... ... national healthcare staffing agency, is honored to announce that Chris ...
(Date:12/16/2009)... Medizone International, Inc. (OTC Bulletin Board: MZEI) ... the Board of Medizone New Zealand Ltd., a ... a 50% interest, agreed on December 14, 2009 ... Medizone International all global marketing rights of the ... G. Marshall said, "Time has eroded the relevance ...
(Date:12/16/2009)... finds 6- to 11-month interval lessens complication risks , , TUESDAY, ... of joy has had such a profound impact on your ... a breath. A new study suggests that you might ... again, and that more than 11 months could be even ... between pregnancies was less than six months, the chances of ...
(Date:12/16/2009)... /PRNewswire-FirstCall/ - TSO3 Inc. ("TSO3") (TSX: TOS) and ... been reached for 3M to be the exclusive ... The partnership with TSO3, an innovator in low ... settings through the use of ozone, will include ... 3M,s global sales channel. This agreement, combined with ...
Breaking Medicine News(10 mins):Health News:Boston University School of Medicine's pulmonary center receives $1.4 million grant 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 3Health News:Medizone International, Inc. Approves Repurchase of Global Marketing Rights 2Health News:For Babies' Sake, Pregnancy Spacing Matters 2Health News:For Babies' Sake, Pregnancy Spacing Matters 3Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 2Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 3Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 4
... Shows Stellar 92 Percent Effective Rate; First For ... lice" become more resistant to some pharmaceutical remedies, ... all-natural head lice product line, Rosemary Repel Hair ... preventing lice from infesting hair follicles.In an in-vitro ...
... is reduced in rodent models of liver injury, ... sulphide, two factors that contribute to endothelial dysfunction ... study the analysis of the human Cystathionase gene ... sequence. Administration of an FXR ligand to carbon ...
... peptide (NP) receptor type B (NPR-B) gene was ... diabetic rats and the expression was increased in ... pGC-cGMP signal is up-regulated and it may contribute ... , Gastroparesis (delayed gastric emptying) is frequent in ...
... Practice and an alliance of businesses in Bucks County, ... and their staff more time to devote to patient ... to help doctors in Bucks County better handle the ... Members of the Bucks County Partners include Doylestown Hospital, ...
... Fixed-dose combination offers a convenient option that may ... pressure goals while decreasing patient pill burden(1)PARSIPPANY, N.J., ... that the United States Food and Drug Administration ... and olmesartan medoxomil) as initial or ,first-line, therapy ...
... Inc. (Nasdaq: GTIV ), a leading provider of ... present at the Deutsche Bank 34th Annual Health Care Conference ... May 19, 2009. The presentations will be available to the ... accessed by visiting http://investors.gentiva.com/events.cfm . ...
Other Medicine News:Health News:'Super Lice' Repelled by All-Natural Products First Ever Independent Study Shows 2Health News:Farnesoid X receptor regulates cystathionase 2Health News:NPs-NPR-B/pGC-cGMP signal pathway is involved in diabetic gastroparesis 2Health News:Physicians Practice and Area Businesses Partner to Improve Patient Care in Bucks County, Pennsylvania 2Health News:Physicians Practice and Area Businesses Partner to Improve Patient Care in Bucks County, Pennsylvania 3Health News:Physicians Practice and Area Businesses Partner to Improve Patient Care in Bucks County, Pennsylvania 4Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 2Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 3Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 4Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 5Health News:AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure 6Health News:Gentiva(R) Health Services to Present at Deutsche Bank 34th Annual Health Care Conference 2Health News:Gentiva(R) Health Services to Present at Deutsche Bank 34th Annual Health Care Conference 3
... for ELISA testing. The system consists of ... Robot, and 1 Plate hotel. The Dade ... of samples from primary tubes via the ... robotic transport system and plate processing via ...
... The Genesis RMP is ideal for ... as for reference and pharmaceutical laboratories. It ... available ELISA and EIA assays from different ... annual throughput of up to 600'000 tests, ...
... IMMULITE and IMMULITE 1000 assays ... the IMMULITE and IMMULITE 1000, ... which offer simplicity in both ... can be found in a ...
... ENA Enzyme-Linked Immunosorbent Assay (ELISA) is intended for ... La, Scl-70, and Jo-1 in human sera. ... detect antibodies in a single serum specimen. ... used as an aid to the diagnosis of ...
Medicine Products: